Literature DB >> 25440880

Organotin complexes containing carboxylate ligands with maleimide and naphthalimide derived partial structures: TrxR inhibition, cytotoxicity and activity in resistant cancer cells.

Kely Navakoski de Oliveira1, Vincent Andermark1, Liliane A Onambele2, Gregor Dahl2, Aram Prokop3, Ingo Ott4.   

Abstract

Di-n-butyltin(IV) carboxylate and tri-n-butyltin(IV) carboxylate derivatives have demonstrated strong cytotoxic effects in different types of tumor cells. Complexes with carboxylate ligands that contain maleimide and naphthalimide derived partial structures were synthesized, characterized and investigated for inhibition of the tumor-relevant enzyme thioredoxin reductase and antiproliferative effects in cancer cells. The complexes were moderate inhibitors of thioredoxin reductase with activities in the micromolar range and triggered strong cytotoxic effects in MCF-7 breast cancer and HT-29 colon carcinoma cells. Interestingly, selected complexes were highly active in vincristine and daunorubicin resistant Nalm-6 cells.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer drugs; Drug resistance; Organotin complexes; Thioredoxin reductase

Mesh:

Substances:

Year:  2014        PMID: 25440880     DOI: 10.1016/j.ejmech.2014.09.075

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processes.

Authors:  Liyan Ji; Simin Yang; Shasha Li; Shan Liu; Shunan Tang; Zhongqiu Liu; Xiangbao Meng; Siwang Yu
Journal:  Oncotarget       Date:  2017-06-06

Review 2.  Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents.

Authors:  Valentina Gandin; Aristi P Fernandes
Journal:  Molecules       Date:  2015-07-14       Impact factor: 4.411

Review 3.  Thioredoxin-dependent system. Application of inhibitors.

Authors:  Anna Jastrząb; Elżbieta Skrzydlewska
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.